Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in Europe

In recent years, the number of trials incorporating health-related quality of life (HRQoL) data has increased. The impact of HRQoL on regulatory decision making in the European context and on clinical practice is not well established. We conducted an analysis of the role of QoL data extracted from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Moscetti, L., Sperduti, I., Frassoldati, A., Musolino, A., Nasso, C., Toss, A., Omarini, C., Dominici, M., Piacentini, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327134/
https://www.ncbi.nlm.nih.gov/pubmed/34304064
http://dx.doi.org/10.1016/j.breast.2021.07.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327134/
https://www.ncbi.nlm.nih.gov/pubmed/34304064
http://dx.doi.org/10.1016/j.breast.2021.07.008

Ejemplares similares